Document Type
Poster
Publication Date
9-12-2020
Identifier/URL
39892249 (Pure)
Abstract
In the United States, 214,880 women are diagnosed with breast carcinomaeach year, with an overall 5-year survival of 90%. When cutaneousmetastases are present, the 5-year survival is 24%. Invasive ductalcarcinoma (IDC) comprises 80% of all breast cancers, with 30% of womenhaving metastatic disease upon initial diagnosis. Cutaneous metastases ofbreast carcinoma occurs at a rate of 24% per primary breast malignancywith 70% of breast carcinoma cutaneous metastases being IDC subtype.Our patient presented as clinically exhibiting features of pseudoxanthomaelasticum (PXE), a genetic disease affecting connective tissue inintertriginous areas, but upon pathologic examination revealed metastaticIDC. Review of the literature has not elicited other reports of PXE-appearingcutaneous breast carcinoma. Recognizing unusual presentations ofcutaneous IDC metastases is vital to early detection and treatment.
Repository Citation
Borchers, C. E.,
Dobkin, H.,
Ingersoll, Z.,
& Handler, M.
(2020). Cutaneous Invasive Ductal Carcinoma Masquerading as Pseudoxanthoma Elasticum. San Diego Dermatology Symposium.
https://corescholar.libraries.wright.edu/dermatology/21
Additional Files
Cutaneous Invasive Ductal Carcinoma Masquerading as Pseudoxanthoma Elasticum.pdf (72 kB)
